Another VCP interactor: NF is enough

Journal of Clinical Investigation

Volumn 121, Issue 12, 2011, Pages 4627-4630

  Weihl, Conrad C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AURORA B KINASE; MUTANT PROTEIN; NEUROFIBROMIN; PROTEASOME; UBIQUITIN CONJUGATING ENZYME; VALOSIN CONTAINING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; CELL NUCLEUS MEMBRANE; DEGENERATIVE DISEASE; DNA REPLICATION; FRONTOTEMPORAL DEMENTIA; GENE DISRUPTION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; MISSENSE MUTATION; NEUROFIBROMATOSIS; NOTE; PAGET BONE DISEASE; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN HOMEOSTASIS; PROTEIN INTERACTION; SKELETAL MUSCLE; SYNAPTOGENESIS;

ADENOSINE TRIPHOSPHATASES; ANIMALS; CELL CYCLE PROTEINS; CONTRACTURE; DENDRITES; FRONTOTEMPORAL DEMENTIA; HUMANS; MYOSITIS, INCLUSION BODY; NEUROFIBROMATOSIS 1; NEUROFIBROMIN 1; OPHTHALMOPLEGIA; OSTEITIS DEFORMANS;

EID: 84055191106     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI61126     Document Type: Note

References (23)

1. Watts GD, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004;36(4):377-381. (Pubitemid 38437260)
2. Weihl CC. Valosin containing protein associated fronto-temporal lobar degeneration: clinical presentation, pathologic features and pathogenesis. Curr Alzheimer Res. 2011;8(3):252-260.
3. Majounie E, et al. Mutational analysis of the VCP gene in Parkinson's disease [published online ahead of print September 13, 2011]. Neurobiol Aging. doi:10.1016/j.neurobiolaging.2011.07.011.
4. Johnson JO, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68(5):857-864.
5. Wang H-F, Shih Y-T, Chen C-Y, Chao H-W, Lee M-J, Hsueh Y-P. Valosin-containing protein and neurofibromin interact to regulate dendritic spine density. J Clin Invest. 2011;121(12):4820-4837.
6. Halawani D, Latterich M. p97: The cell's molecular purgatory? Mol Cell. 2006;22(6):713-717.
7. Ramadan K, et al. Cdc48/p97 promotes reformation of the nucleus by extracting the kinase Aurora B from chromatin. Nature. 2007;450(7173):1258-1262.
8. Rabinovich E, Kerem A, Frohlich KU, Diamant N, Bar- Nun S. AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol Cell Biol. 2002;22(2):626-634. (Pubitemid 34027506)
9. Dreveny I, et al. p97 and close encounters of every kind: a brief review. Biochem Soc Trans. 2004; 32(pt 5):715-720. (Pubitemid 39524361)
10. Ritz D, et al. Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations. Nat Cell Biol. 2011;13(9):1116-1123.
11. Fernandez-Saiz V, Buchberger A. Imbalances in p97 co-factor interactions in human proteinopathy. EMBO Rep. 2010;11(6):479-485.
12. Ju JS, Miller SE, Hanson PI, Weihl CC. Impaired protein aggregate handling and clearance underlie the pathogenesis of p97/VCP-associated disease. J Biol Chem. 2008;283(44):30289-30299.
13. Ju JS, et al. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J Cell Biol. 2009;187(6):875-888.
14. Tanaka A, et al. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J Cell Biol. 2010;191(7):1367-1380.
15. Weihl CC, Dalal S, Pestronk A, Hanson PI. Inclusion body myopathy-associated mutations in p97/ VCP impair endoplasmic reticulum-associated degradation. Hum Mol Genet. 2006;15(2):189-199. (Pubitemid 43125974)
16. Janiesch PC, et al. The ubiquitin-selective chaperone CDC-48/p97 links myosin assembly to human myopathy. Nat Cell Biol. 2007;9(4):379-390. (Pubitemid 46511071)
17. Landsverk ML, et al. The UNC-45 chaperone mediates sarcomere assembly through myosin degradation in Caenorhabditis elegans. J Cell Biol. 2007;177(2):205-210. (Pubitemid 46658632)
18. Phan VT, Ding VW, Li F, Chalkley RJ, Burlingame A, McCormick F. The RasGAP proteins Ira2 and neurofibromin are negatively regulated by Gpb1 in yeast and ETEA in humans. Mol Cell Biol. 2010;30(9):2264-2279.
19. Sugita S, Sudhof TC. Specificity of Ca2+-dependent protein interactions mediated by the C2A domains of synaptotagmins. Biochemistry. 2000;39(11):2940-2949. (Pubitemid 30159399)
20. Clemen CS, et al. Strumpellin is a novel valosincontaining protein binding partner linking hereditary spastic paraplegia to protein aggregation diseases. Brain. 2010;133(10):2920-2941.
21. Valdmanis PN, et al. Mutations in the KIAA0196 gene at the SPG8 locus cause hereditary spastic paraplegia. Am J Hum Genet. 2007;80(1):152-161. (Pubitemid 46047658)
22. Rumpf S, Lee SB, Jan LY, Jan YN. Neuronal remodeling and apoptosis require VCP-dependent degradation of the apoptosis inhibitor DIAP1. Development. 2011;138(6):1153-1160.
23. Shilyansky C, Lee YS, Silva AJ. Molecular and cellular mechanisms of learning disabilities: a focus on NF1. Annu Rev Neurosci. 2010;33:221-243.